跳至主要内容
临床试验/NCT01005381
NCT01005381已完成不适用

The Effect of Particle Size of Calcium Carbonate and Vitamin D on Calcium and Bone Parameters in Adolescent Girls

Purdue University2 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2007年6月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
55
试验地点
2
主要终点
Calcium Balance

研究概览

简要总结

This study has two research arms:

The purpose of the 1st is to determine if a smaller particle size calcium carbonate supplement (than that which is now commercially available) improves calcium absorption and retention in adolescents girls.

The purpose of the 2nd is to determine if vitamin D supplementation improves calcium absorption and retention in adolescents girls.

详细描述

An important strategy to reducing the risk for osteoporosis and fracture in later life is to optimize the development of peak bone mass during adolescence. Because calcium is the main mineral component of bone, maximizing calcium absorption and retention during adolescence is important to maximize peak bone mass.

Our two research arms address two different mechanisms by which calcium absorption and retention may be increased:

  1. We hypothesize that a smaller particle size calcium carbonate supplement (than that which is now commercially available) may be better absorbed and lead to higher calcium retention in adolescents.
  2. We hypothesize that vitamin D supplementation will increased calcium absorption and retention in adolescents.

Subjects will be assigned to one of the two research arms.

1)Small and large particle size calcium supplements or placebo or 2) calcium supplements with or without vitamin D supplements will be given to subjects during two 3-week study periods in which subjects live on-site.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
12 Years 至 14 Years(Child)
性别
Female
接受健康志愿者

入选标准

  • 12-14 year old girls
  • Generally Healthy

排除标准

  • History of alcohol, smoking, or non-prescription drug use
  • Malabsorptive disorders, bone, liver, or kidney disease that may affect calcium metabolism
  • Oral contraceptive use
  • Pregnancy

研究组 & 干预措施

Small Particle Size Calcium Carbonate

Experimental

Subjects are given small particle size calcium carbonate supplement twice daily (total of 625 mg/d from supplement).

干预措施: Small Particle Size Calcium Carbonate Supplement (Dietary Supplement)

Large Particle Size Calcium Carbonate

Active Comparator

Subjects are given a large particle size calcium carbonate supplement twice daily (total of 625 mg/d from supplement).

干预措施: Large Particle Size Calcium Carbonate Supplement (Dietary Supplement)

Calcium Placebo

Placebo Comparator

Subjects are given two placebo tablets daily, which are identical to the large and small particle size calcium carbonate supplements.

干预措施: Calcium Placebo (Dietary Supplement)

No Vitamin D supplement

Active Comparator

Subjects are given calcium carbonate supplement once daily (325 mg/d from supplement).

干预措施: Small Particle Size Calcium Carbonate Supplement (Dietary Supplement)

Vitamin D supplement

Experimental

Subjects are given a calcium supplement once daily (325 mg/d from supplement) with 1000 IU/d vitamin D supplement.

干预措施: Small Particle Size Calcium Carbonate Supplement (Dietary Supplement)

Vitamin D supplement

Experimental

Subjects are given a calcium supplement once daily (325 mg/d from supplement) with 1000 IU/d vitamin D supplement.

干预措施: Vitamin D (Dietary Supplement)

结局指标

主要结局

Calcium Balance

时间窗: weeks 2,3 + 5,6

Total calcium(Ca) retention will be calculated - Ca retention/d = Ca intake/d - Ca excretion/d (urine + feces)

Calcium Absorption

时间窗: Day 15, 30

次要结局

  • Serum parathyroid hormone suppression(Day 19, 40)
  • Serum 25-hydroxyvitamin D(Day 1, 20, 2, 41)
  • Urinary Calcium(Weeks 2,3 + 5,6)
  • Fecal Calcium(Weeks 2,3 + 5,6)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Berdine Martin

Research Scientist, Nutrition Science

Purdue University

研究点 (2)

Loading locations...

相似试验